蒋宇亮 / Jiang Yuliang

Overview

蒋宇亮 is a gastroenterology doctor in five ingested 这病说来话长 episodes, contributing first-visit and abdominal-pain triage, liver-health education, digestive listener Q&A, anorectal and probiotic education, and a multidisciplinary constipation discussion. The supplied VOL.94 and VOL.148 notes render his name as 江宇亮, which the wiki preserves as a source-level spelling variation.

Current Profile

The source presents 蒋宇亮 as the clinician most associated with first-visit triage and abdominal-pain complexity. His explanation starts from chief complaint, symptom duration, and fixed follow-up questions, then moves to a safety priority: screen dangerous or fatal disease before settling into ordinary symptomatic treatment.

His examples also make follow-up a clinical responsibility. After ordering tests, he stresses that patients should return when results are available, and higher-risk cases may need contact information, emergency observation, or referral to a more experienced subspecialist.

VOL.156 extends that safety logic into liver health. He explains why liver injury may be difficult to feel, treats fatty-liver and liver-function findings as reasons for cause review, warns about medicine and herbal-product injury, and places alcohol practices behind an explicit harm boundary. His practical priority is lifestyle and exposure correction before clinician-guided treatment when warranted.

VOL.94 applies the same risk-stratified style to common digestive questions. Bloating, loose stool, constipation, and gas are explained through motility, digestion, behavior, or microbiome context without dismissing bleeding, severe reflux, family cancer history, high-risk pathology, or persistent symptoms. Endoscopy is presented as a pathway completed by tissue pathology and individualized follow-up rather than a one-time visual check.

VOL.179 adds a mechanism-to-triage explanation of bowel function. He connects rectal sensing and coordinated propulsion and sphincter control to the ability to distinguish gas, liquid, and solid contents, then explains why diarrhea, infection, aging, immobility, or pelvic-floor decline can impair that process. He treats gas frequency, odor, sound, and stool appearance as contextual observations, keeps bleeding and abnormal stool colors inside clinical evaluation, and frames probiotics as condition- and person-dependent rather than routine health products.

VOL.148 consolidates that bowel-health reasoning into Chronic Constipation Recognition and Management. It distinguishes occasional difficulty from a persistent symptom cluster, separates organic obstruction from transit and evacuation disorders, places fluid, fiber, movement, and bowel timing before routine laxative use, and escalates bleeding or persistent stool-shape change. Its exact diagnostic thresholds, product claims, and treatment details remain source-scoped.

Key Characteristics

• Explains first visits as structured history-taking around the chief complaint.
• Prioritizes dangerous-disease screening before routine symptomatic management.
• Uses abdominal pain to show how ordinary complaints can require broad differential diagnosis.
• Treats test-result follow-up and escalation routes as part of diagnosis.
• Translates silent liver injury, fatty-liver progression, alcohol, medicines, supplements, diet, and sleep into cause-based prevention and follow-up questions.
• Keeps product, medication, and drinking-practice claims inside qualified-care and source-scope boundaries.
• Uses anorectal function, constipation mechanism, pathology, lesion risk, stool warning signs, family history, and symptom severity to separate routine digestive self-care from specialist escalation.

Evidence

• Structured triage: VOL.218韩杰医生事件后四大门诊坦白局：不对立不甩锅，医患如何联手打赢防漏诊的“排雷战”？ has 蒋宇亮 describe starting with where discomfort is, how long it has lasted, and what dangerous disease must be excluded.
• Test follow-up: VOL.218韩杰医生事件后四大门诊坦白局：不对立不甩锅，医患如何联手打赢防漏诊的“排雷战”？ has him tell patients to return after lab results and consider emergency observation or contact channels for higher-risk cases.
• Abdominal-pain ambiguity: VOL.218韩杰医生事件后四大门诊坦白局：不对立不甩锅，医患如何联手打赢防漏诊的“排雷战”？ uses abdominal pain to connect digestive organs, severe hidden disease, and even non-digestive causes such as cardiac pain.
• Liver detection and cause review: VOL.156爱肝护肝第一步你就走错了 沉默的“人体化工厂”自救指南 has 蒋宇亮 explain limited early pain signaling, liver-function and imaging findings, fatty-liver progression, and the need to review alcohol, food, activity, medicines, supplements, and body state.
• Harm and treatment boundaries: VOL.156爱肝护肝第一步你就走错了 沉默的“人体化工厂”自救指南 warns that drinking rituals do not cancel alcohol exposure and keeps liver-protection medication, timing, and monitoring under clinician guidance.
• Digestive symptom triage: VOL.94消化内科｜困扰当代年轻人的最多肠胃问题就是胀气｜答疑篇 links bloating, loose stool, constipation, gas, and dyspepsia to context while escalating visible blood, severe reflux, persistent symptoms, and family cancer history.
• Pathology-guided follow-up: VOL.94消化内科｜困扰当代年轻人的最多肠胃问题就是胀气｜答疑篇 emphasizes tissue pathology and risk-specific surveillance after polyps, dysplasia, ESD, or prior abnormal examinations.
• Anorectal discrimination and bowel coordination: VOL.179放屁前怎么辨别是屁还是便？憋屁真的会损害身体？ connects rectal sensing, neural interpretation, propulsion, and sphincter control to gas-versus-stool discrimination, constipation, and continence.
• Gas, stool, and product boundaries: VOL.179放屁前怎么辨别是屁还是便？憋屁真的会损害身体？ treats gas and stool appearance as contextual signals, escalates bleeding or abnormal color patterns, and rejects probiotics as a universal healthy-person necessity.
• Constipation classification and first-line care: VOL.148你为拉屎做过哪些努力？有的可能不是便秘，但有的需要警惕！ distinguishes short-lived difficulty from persistent constipation, separates organic from functional subtypes, and puts combined lifestyle support before routine laxative use.
• Constipation escalation: VOL.148你为拉屎做过哪些努力？有的可能不是便秘，但有的需要警惕！ routes bleeding, persistent shape change, and possible intraluminal or external obstruction toward structured assessment.

Qualifications

The page is based only on five episode notes. It does not independently verify 蒋宇亮’s full institutional affiliation or credentials beyond the sources’ gastroenterology role. VOL.94 and VOL.148 call the guest 江宇亮 and VOL.94 names Beijing You’an Hospital; later notes use 蒋宇亮, while another source has a distinct 蒋永亮 record. The wiki does not treat these spellings as independently verified identity evidence. Disease timelines, nutrition and exercise mechanisms, alcohol practices, anorectal mechanisms, constipation thresholds, stool-color and stool-shape associations, probiotic effects, endoscopy intervals, and treatment discussion remain source-scoped public education rather than individualized care.

What Changed

• Added explicit constipation classification, lifestyle-first management, and obstruction-warning context.
• Extended the source-level 江宇亮 spelling variation to VOL.148 without merging him into the distinct 蒋永亮 record.
• Kept exact thresholds, stool-shape claims, product mechanisms, and treatment details qualified and source-scoped.

Relationships

• 这病说来话长 / Zhe Bing Shuo Lai Hua Chang - show where he appears as a medical guest.
• Missed Diagnosis Risk / 漏诊风险 - risk frame his abdominal-pain examples make visible.
• Diagnostic Safety Netting / 诊断安全网 - follow-up route he emphasizes after tests and uncertain triage.
• Medical Diagnostic Reasoning - reasoning pattern behind chief-complaint questioning and dangerous-disease screening.
• Medical Risk Management - safety frame behind escalation to emergency observation or contact follow-up.
• Silent Liver Damage Detection - testing and follow-up boundary he explains for an organ that may not hurt early.
• Fatty Liver Cause-Directed Management - lifestyle, exposure, and treatment framework he develops in VOL.156.
• Herbal Supplement Liver Toxicity - medicine and unverified herbal-product risk he highlights.
• Alcohol Liver Harm Boundary - distinction he draws between reducing discomfort and preventing liver harm.
• Bowel Symptom Triage - digestive warning-sign and ordinary-symptom distinction he explains in VOL.94.
• Endoscopy Pathology and Follow-up / 内镜病理与复诊闭环 - pathology and risk-specific return-review model he reinforces in VOL.94.
• Colon Polyp Risk Stratification - polyp-type, dysplasia, treatment, and surveillance distinction he discusses.
• Flatulence As Health Signal / 排气作为健康信号 - gas-production, retention, motility, and escalation context he explains.
• Anorectal Sensation and Coordination - rectal discrimination and muscle-coordination framework he develops in VOL.179.
• Probiotic Use Boundary - condition- and person-specific boundary he applies to probiotic use.
• Chronic Constipation Recognition and Management - classification, first-line support, and escalation framework he develops in VOL.148.